77 related articles for article (PubMed ID: 21319993)
21. Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma.
Spitz R; Betts DR; Simon T; Boensch M; Oestreich J; Niggli FK; Ernestus K; Berthold F; Hero B
Cancer Genet Cytogenet; 2006 May; 167(1):51-6. PubMed ID: 16682287
[TBL] [Abstract][Full Text] [Related]
22. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma.
Azuhata T; Scott D; Takamizawa S; Wen J; Davidoff A; Fukuzawa M; Sandler A
J Pediatr Surg; 2001 Dec; 36(12):1785-91. PubMed ID: 11733907
[TBL] [Abstract][Full Text] [Related]
23. The prognostic significance of vanillylmandellic acid in neuroblastoma.
Aydin GB; Kutluk MT; Yalcin B; Varan A; Akyuz C; Buyukpamukcu M
Pediatr Hematol Oncol; 2010 Sep; 27(6):435-48. PubMed ID: 20578806
[TBL] [Abstract][Full Text] [Related]
24. Molecular pathogenesis of peripheral neuroblastic tumors.
Janoueix-Lerosey I; Schleiermacher G; Delattre O
Oncogene; 2010 Mar; 29(11):1566-79. PubMed ID: 20101209
[TBL] [Abstract][Full Text] [Related]
25. Neuroblastoma metastatic to the central nervous system. The Memorial Sloan-kettering Cancer Center Experience and A Literature Review.
Kramer K; Kushner B; Heller G; Cheung NK
Cancer; 2001 Apr; 91(8):1510-9. PubMed ID: 11301399
[TBL] [Abstract][Full Text] [Related]
26. Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients.
Passoni L; Longo L; Collini P; Coluccia AM; Bozzi F; Podda M; Gregorio A; Gambini C; Garaventa A; Pistoia V; Del Grosso F; Tonini GP; Cheng M; Gambacorti-Passerini C; Anichini A; Fossati-Bellani F; Di Nicola M; Luksch R
Cancer Res; 2009 Sep; 69(18):7338-46. PubMed ID: 19723661
[TBL] [Abstract][Full Text] [Related]
27. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
George RE; London WB; Cohn SL; Maris JM; Kretschmar C; Diller L; Brodeur GM; Castleberry RP; Look AT
J Clin Oncol; 2005 Sep; 23(27):6466-73. PubMed ID: 16116152
[TBL] [Abstract][Full Text] [Related]
28. A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage.
Hoehner JC; Gestblom C; Hedborg F; Sandstedt B; Olsen L; Påhlman S
Lab Invest; 1996 Nov; 75(5):659-75. PubMed ID: 8941212
[TBL] [Abstract][Full Text] [Related]
29. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
Ladenstein R; Ambros PF; Urban C; Ambros IM; Fink FM; Zoubek A; Grienberger H; Schmitt K; Kerbl R; Horcher E; Amann G; Höfler G; Heinzl H; Gadner H; Mutz I
Klin Padiatr; 1996; 208(4):210-20. PubMed ID: 8926686
[TBL] [Abstract][Full Text] [Related]
30. Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma.
Spitz R; Hero B; Ernestus K; Berthold F
Clin Cancer Res; 2003 Oct; 9(13):4835-40. PubMed ID: 14581355
[TBL] [Abstract][Full Text] [Related]
31. Intragenic anaplastic lymphoma kinase (ALK) rearrangements: translocations as a novel mechanism of ALK activation in neuroblastoma tumors.
Fransson S; Hansson M; Ruuth K; Djos A; Berbegall A; Javanmardi N; Abrahamsson J; Palmer RH; Noguera R; Hallberg B; Kogner P; Martinsson T
Genes Chromosomes Cancer; 2015 Feb; 54(2):99-109. PubMed ID: 25251827
[TBL] [Abstract][Full Text] [Related]
32. Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome.
Spitz R; Oberthuer A; Zapatka M; Brors B; Hero B; Ernestus K; Oestreich J; Fischer M; Simon T; Berthold F
Genes Chromosomes Cancer; 2006 Dec; 45(12):1130-42. PubMed ID: 16958102
[TBL] [Abstract][Full Text] [Related]
33. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.
Hsu WM; Lee H; Juan HF; Shih YY; Wang BJ; Pan CY; Jeng YM; Chang HH; Lu MY; Lin KH; Lai HS; Chen WJ; Tsay YG; Liao YF; Hsieh FJ
Clin Cancer Res; 2008 Oct; 14(19):6237-45. PubMed ID: 18829503
[TBL] [Abstract][Full Text] [Related]
34. Neuroblastoma: paradigm for precision medicine.
Irwin MS; Park JR
Pediatr Clin North Am; 2015 Feb; 62(1):225-56. PubMed ID: 25435121
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma.
Mora J; Lavarino C; Alaminos M; Cheung NK; Ríos J; de Torres C; Illei P; Juan G; Gerald WL
Genes Chromosomes Cancer; 2007 Apr; 46(4):385-96. PubMed ID: 17243159
[TBL] [Abstract][Full Text] [Related]
36. Characterization of rearrangements involving the ALK gene reveals a novel truncated form associated with tumor aggressiveness in neuroblastoma.
Cazes A; Louis-Brennetot C; Mazot P; Dingli F; Lombard B; Boeva V; Daveau R; Cappo J; Combaret V; Schleiermacher G; Jouannet S; Ferrand S; Pierron G; Barillot E; Loew D; Vigny M; Delattre O; Janoueix-Lerosey I
Cancer Res; 2013 Jan; 73(1):195-204. PubMed ID: 23139213
[TBL] [Abstract][Full Text] [Related]
37. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
[TBL] [Abstract][Full Text] [Related]
38. Correlation between morphologic and nonmorphologic prognostic markers of neuroblastoma.
Joshi VV; Tsongalis GJ
Ann N Y Acad Sci; 1997 Sep; 824():71-83. PubMed ID: 9382456
[TBL] [Abstract][Full Text] [Related]
39. Multiple Genes with Potential Tumor Suppressive Activity Are Present on Chromosome 10q Loss in Neuroblastoma and Are Associated with Poor Prognosis.
Ognibene M; De Marco P; Amoroso L; Cangelosi D; Zara F; Parodi S; Pezzolo A
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046696
[TBL] [Abstract][Full Text] [Related]
40. The mitochondrial genetic landscape in neuroblastoma from tumor initiation to relapse.
Riehl LM; Schulte JH; Mulaw MA; Dahlhaus M; Fischer M; Schramm A; Eggert A; Debatin KM; Beltinger C
Oncotarget; 2016 Feb; 7(6):6620-5. PubMed ID: 26735174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
